September 19, 2018 - On the 11 and 12of September, scientists from leading research organizations across the world met for the ZikaPLAN Consortium meeting at the London School of Hygiene & Tropical Medicine in the UK. Read more
July 9, 2018 - ZikaPLAN’s NEURO-ZIKA neurological manifestations working group leader, the University of Liverpool, has been working with another working group member, Fiocruz, and the Brazilian Ministry of Health, the Brazilian charities ‘Uniao de Maes dos Anjos-UMA’ (Recife), ‘Associação ... Read more
July 3, 2018 - NEURO-ZIKA pathogenesis work in ZikaPLAN is differentiating autoimmune versus direct neuropathic phenomena of ZIKV to impact both clinical care and basic understanding of disease. Read more
June 27, 2018 - Over 80% of the world’s population is at risk from vector-borne diseases, yet no single, all-encompassing resource for the researchers and health workers involved in vector-borne disease control exists today. The aim of the Global Vector ... Read more
Nidya A. Segura Guerrero et al – Antiviral Research, October 29, 2018
The ZikaPLAN and ZIKAlliance authors of this study show that the Usutu virus (USUV) infection model in mice is suitable for assessing the potential in vivo efficacy of novel USUV/flavivirus inhibitors.
Defining the spectrum of neurological diseases associated with Zika virus (ZIKV) infection, in both the central nervous system (CNS) and peripheral nervous system (PNS) of adults and children.
To protect pregnant women, novel, wash-in detergent formulations and long-lasting plastic technologies containing repellents for the treatment of clothing and other wearable repellent technologies are being developed using new microencapsulation techniques.
Identifying the major T-cell epitopes and cross reactive B-cell epitopes on ZIKV and assessing the role of flavivirus antibodies in protective and pathogenic immunity following ZIKV through antibody dependent enhancement (ADE).
ZikaPLAN has received funding from the European Union’s Horizon 2020 research and innovation programme under grant agreement No 734584.